| Location |
Principal Investigator |
Technology/Reagents |
Pathogen/Role |
| Albert Einstein College of Medicine |
Dr. Ruth Angeletti |
Mass spectrometry Bioinformatics/
Apicomplexa and
Membrane Antibodies |
Category B priority pathogens: Toxoplasma gondii, Cryptosporidium parvum |
| Caprion Pharmaceuticals, Inc.; University of Montreal |
Dr. Eustache Paramithiotis (Caprion)
Co-Principal Investigator/Additional Contact: Dr. Daniel Chelsky |
Mass spectrometry |
Category B priority pathogen: Brucella abortus |
| Harvard Medical School; Massachusetts General Hospital |
Dr. Joshua LaBaer (Harvard) |
NAPPA arrays/ Clones |
Category A priority pathogen:Bacillus anthracis
Category B priority pathogen: Vibrio cholerae |
| Myriad Genetics, Inc; SUNY, Stonybrook; University of California, Los Angeles; Robarts Research Institute |
Dr. Jerry Lanchbury (Myriad Genetics) |
Yeast 2 Hybrid protein interactions/ Clones |
Category A priority pathogens: Bacillus anthracis, Yersinia pestis, Francisella tularensis, vaccinia, Variola |
| Pacific Northwest National Laboratory; Oregon Health Sciences University |
Dr. Richard Smith (PNNL)
Co-Principal Investigator/Additional Contact: Dr. Joshua Adkins |
Mass spectrometry/
Bacteria |
Category A priority pathogens: Orthopox (vaccinia and monkeypox)
Category B priority pathogens: Salmonella typhimurium and Salmonella typhi |
| The Scripps Research Institute; Burnham Institute; Palo Alto Research Center |
Dr. Peter Kuhn (Scripps) |
3-D protein structures/
Clones |
Category C priority pathogens: Influenza
Emerging/Re-Emerging Infectious Disease: SARS CoV |
| University of Michigan; The Scripps Research Institute |
Dr. Phillip Hanna (U. Michigan |
Mass spectrometry Microarrays/ Arraychip |
Category A priority pathogen:Bacillus anthracis |
| Social & Scientific Systems, Inc. (SSS); Virginia Bioinformatics Institute; Georgetown University |
Ms. Margaret Moore (SSS) |
|
The Administrative Resource Center has developed and maintains a publicly accessible web site containing data and technology protocols generated by each PRC, as well as a catalog that lists reagents and products developed by the sites and available for public distribution. (non-government link) |